What's New Since 2002? The primary objective in selecting a treatment strategy in UA/NSTEMI is to choose an approach likely to yield the best long-term clinical outcome. Two treatment pathways ...

Still, the ideal treatment of cocaine-associated NSTEMI isn’t clear: there are no randomized, placebo-controlled trials in this setting. In 2014, the American College of Cardiology (ACC) and AHA ...

The American Heart Association (AHA) and American College of Cardiology (ACC) have issued new performance and quality measures for the treatment of patients with STEMI and NSTEMI, abandoning some ...

In November 2009, Effient also was added as a Class I recommended treatment in AHA/ACC/SCAI clinical guidelines for patients with UA or NSTEMI receiving PCI and for patients with ST elevation ...

Several STEMI/NSTEMI performance measures have been proposed by ACC/AHA, and endorsed by multiple organizations, to ensure effective, timely, safe, efficient, and patient-centered medical care ...

which were reported at the AHA meeting last year, confirmed that bivalirudin is preferable to abciximab plus heparin as adjunctive antithrombotic treatment in NSTEMI patients undergoing PCI ...

NSTEMI stands for non-ST segment elevation myocardial infarction, which is a type of heart attack. Compared to the more common type of heart attack known as STEMI, an NSTEMI is typically less ...

A non-ST segment elevation myocardial infarction, also called an NSTEMI or a non-STEMI, is a type of heart attack. While it's often less damaging to your heart than a STEMI, it's still a serious ...

Acute myocardial infarction with or without ST-segment elevation (STEMI or non-STEMI) is a common cardiac emergency, with the potential for substantial morbidity and mortality. The management of ...